- Breaking News San Mateo County ninth-graders struggle to stay fit
- Breaking News Food and wine events
- Breaking News Ask Amy: What To Do When the Doctor Isn t in the House
- Breaking News Ed Blonz: Keep your diet normal pre-surgery
CTIC, ENOC, FELE, GIGM, MALL, NABI Have Also Been Removed From Naked Short List Today.
0 Comments | M2 Presswire, April, 2008
M2 PRESSWIRE-3 April 2008-BUYINS.NET: CTIC, ENOC, FELE, GIGM, MALL, NABI Have Also Been Removed From Naked Short List Today(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:03042008
BUYINS.NET, www.buyins.net.
Cell Therapeutics Inc. (NASDAQ: CTIC) markets lymphoma drug, Zevalin, in the United States. Zevalin is an FDA-approved radioimmunotherapeutic for treating lymphoma. The company also develops, acquires, and commercializes novel treatments for cancer. In addition, Cell Therapeutics develops XYOTAX for the treatment of non-small cell lung cancer and ovarian cancer; Pixantrone, a novel compound in the class of drugs known as anthracyclines, for non-Hodgkin's lymphoma; and Brostallicin, which is in first-line Phase II study for the treatment of...
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Portfolio forecasting tools: what you need to know
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Industry Experts Launch Money Management Resources to Help People Overcome Debt and Learn Proper Money Management Practices
- Building successful logistics partnerships
- Banking technology, technological learning and competition: comparative case studies in Thai banking
- John Seely Brown Inducted Into 2004 Industry Hall of Fame
- SmartDisk's New VST Flash Media Reader(TM) Reads SmartMedia(TM), CompactFlash(TM) From A Single Desktop Unit